Combinations of drugs in the Treatment of Obesity
Obesity is a chronic disease associated with excess morbidity and mortality. Clinical treatment, however, currently offers disappointing results, with very high rates of weight loss failure or weight regain cycles, and only two drugs (orlistat and sibutramine) approved for long-term use. Drugs combi...
Main Authors: | Marcio C. Mancini, Maria Edna de Melo, Cintia Cercato, Alfredo Halpern, André M. Faria, Eduardo S. L. Oliveira, Bruno Halpern |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2010-07-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | http://www.mdpi.com/1424-8247/3/8/2398/ |
Similar Items
-
Anti-Obesity Drugs: Long-Term Efficacy and Safety: An Updated Review
by: Young Jin Tak, et al.
Published: (2021-04-01) -
Current Long-Term Pharmacotherapies for the Management of Obesity
by: Bo-Yeon Kim, et al.
Published: (2020-06-01) -
Current obesity drug treatment
by: Marcio C. Mancini, et al.
Published: (2006-03-01) -
Perspectives of drug treatment of obesity
by: Alfredo Halpern, et al.
Published: (2006-03-01) -
The Triple Combination Phentermine Plus 5-HTP/Carbidopa Leads to Greater Weight Loss, With Fewer Psychomotor Side Effects Than Each Drug Alone
by: Claudia I. Perez, et al.
Published: (2019-11-01)